AxoGen (NASDAQ:AXGN – Get Free Report) announced its quarterly earnings data on Wednesday. The company had revenue of $69.73 million during the quarter, compared to analyst estimates of $67.10 million. Weiss Ratings reiterated a “sell (d-)” rating on shares of AxoGen in a research note on Friday, May 29th. Also, Director Kathy Johnson Weiler sold 16,344 shares of AxoGen stock in a transaction on Thursday, May 7th. Finally, Soleus Capital Management L.P. raised its stake in shares of AxoGen by 0.9% during the second quarter.